Proteomics

Dataset Information

0

Cyclipostins and Cyclophostin analogs impair growth of Mycobacterium abscessus by inhibiting enzymes involved in many physiological processes


ABSTRACT: Mycobacterium abscessus is nowadays under the spotlight of the scientific community. This pathogenic mycobacteria is indeed responsible for a wide spectrum of infections involving mostly pulmonary infections in patients with cystic fibrosis. M. abscessus is intrinsically resistant to a broad range of antibiotics, including most antitubercular drugs, and is considered the most pathogenic and chemotherapy-resistant rapidly growing mycobacterium. Consequently, with very limited treatment options, the development of new therapeutic approaches to fight this pathogen are urgently needed. 38 new analogs of Cyclipostins & Cyclophostin (CyC), compounds naturally produced by Streptomyces species, have been synthesized. Their antibacterial activities against clinical isolates belonging to the M. chelonae-abscessus clade, as well as Gram-negative and Gram-positive bacteria have been evaluated by the REMA method. The intracellular activities of the CyC against intramacrophagic M. abscessus have also been investigated and compared to those of imipenem. The CyCs displayed very low toxicity towards host cells and their inhibitory activity was exclusively restricted to mycobacteria. The best candidate, CyC17, showed a high selectivity for mycobacteria with MIC values (<2 up to 40 µg/mL) comparable to those of most classical antibiotics used to treat M. abscessus infections. Of importance, several CyCs were active against extracellular M. abscessus growth (i.e., CyC17 / CyC18β / CyC25 / CyC26) or against intracellular mycobacteria inside macrophages (i.e., CyC7α,β / CyC8α,β) with MIC values similar to or better than those of standard antibiotics. Based on these results, we intended to identify the potential target enzymes of CyC17/CyC26 in M. abscessus by activity-based protein profiling (ABPP) approach coupled with mass spectrometry differential analysis.

INSTRUMENT(S): Orbitrap Fusion Lumos, LTQ Orbitrap Velos

ORGANISM(S): Mycobacterium Abscessus (strain Atcc 19977 / Dsm 44196 / Cip 104536 / Jcm 13569 / Nctc 13031 / Tmc 1543)

SUBMITTER: Luc Camoin  

LAB HEAD: Luc Camoin

PROVIDER: PXD014255 | Pride | 2019-10-08

REPOSITORIES: Pride

altmetric image

Publications


Twelve new Cyclophostin and Cyclipostins analogues (<b>CyC</b><sub><b>19</b>-<b>30</b></sub>) were synthesized, thus extending our series to 38 <b>CyCs</b>. Their antibacterial activities were evaluated against four pathogenic mycobacteria (<i>Mycobacterium abscessus</i>, <i>Mycobacterium marinum</i>, <i>Mycobacterium bovis</i> BCG, and <i>Mycobacterium tuberculosis</i>) and two Gram negative bacteria. The <b>CyCs</b> displayed very low toxicity toward host cells and were only active against myc  ...[more]

Similar Datasets

2020-08-14 | PXD015680 | Pride
2020-07-17 | PXD020259 | Pride
2019-10-22 | PXD015026 | Pride
2023-09-02 | PXD043836 | Pride
2021-08-06 | PXD027493 | Pride
2020-07-21 | PXD018749 | Pride
2022-02-15 | PXD018691 | Pride
2023-07-02 | PXD037436 | Pride
2018-10-18 | PXD005985 | Pride
2017-12-19 | PXD006837 | Pride